Sign up
Quantellect · Congress · Trade Detail
NASDAQ: BIIBBiogen Inc
DemocratHouse

Josh Gottheimer sold Biogen Inc (NASDAQ: BIIB)

Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 9 trades in Biogen Inc (BIIB) since 2018, 5 purchases and 4 sales, worth an estimated $72K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Biogen Inc (NASDAQ: BIIB) on September 15, 2021. Since that trade, BIIB is down -30.51% against the S&P 500 up +76.73%, an outperformance of -107.24%.

Across these filings, Josh Gottheimer has been a net buyer of BIIB (a buy-to-sell ratio of 1.25). The most recent disclosed BIIB transaction shown was dated March 17, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BIIB trades
9
Disclosed Vol
$72K
Buys
5
56%
Sells
4
44%
Buy / Sell
1.25
ratio
First → Last
2018–2022

Josh Gottheimer's BIIB trades vs the price

BIIB is down -30.51% since Josh Gottheimer sold on September 15, 2021, versus +76.73% for the S&P 500.

Performance since this trade

Price change since trade
-30.51%
S&P 500 change since trade
+76.73%
Outperformance vs S&P 500
-107.24%

All Josh Gottheimer BIIB trades

TradedTypeSizeReturnEst. profit
March 17, 2022SELL$205.32+1.27%
January 10, 2022BUY$235.31-11.64%-$887
December 9, 2021SELL$232.43-10.54%
October 18, 2021BUY$269.73-22.91%-$2K
September 15, 2021SELL$299.21-30.51%
June 8, 2021BUY$395.37-47.41%-$4K
July 7, 2020BUY$268.35-22.52%-$2K
October 29, 2018SELL$300.96-30.91%
July 24, 2018BUY$372.84-44.23%-$4K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Josh Gottheimer & BIIB trading FAQ

Is it legal for Josh Gottheimer to trade Biogen Inc (BIIB) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Biogen Inc (BIIB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Josh Gottheimer sell BIIB?

Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Biogen Inc (BIIB) on September 15, 2021, according to public STOCK Act filings.

How has BIIB performed since Josh Gottheimer's trade?

Since Josh Gottheimer sold BIIB on September 15, 2021, the stock is down -30.51%, versus +76.73% for the S&P 500 over the same period, an outperformance of -107.24%.

How many times has Josh Gottheimer traded BIIB?

Josh Gottheimer has disclosed 9 BIIB trades since 2018 (5 purchases and 4 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BIIB trades?

Quantellect tracks every disclosed congressional trade in Biogen Inc (BIIB) on the Biogen Inc congressional trading page, which aggregates filings across all members of Congress.

Josh Gottheimer's BIIB tradesAll congressional filings for Biogen IncJosh Gottheimer's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.